EDITAS MEDICINE, INC. (EDIT)

3.16 -4.24% (-0.14)

Over 1M: +22.5%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2.75 3 3.25
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 6.2M Q3 '21 — Operating Cash Flow: -40.8M Q3 '21 — Free Cash Flow: -43.1M Q3 '21 — Net Income: -39.1M Q4 '21 — Revenue: 12.5M Q4 '21 — Operating Cash Flow: -34.6M Q4 '21 — Free Cash Flow: -37.4M Q4 '21 — Net Income: -41.4M Q1 '22 — Revenue: 6.8M Q1 '22 — Operating Cash Flow: -49.2M Q1 '22 — Free Cash Flow: -51.5M Q1 '22 — Net Income: -50.5M Q2 '22 — Revenue: 6.4M Q2 '22 — Operating Cash Flow: -37.8M Q2 '22 — Free Cash Flow: -38.5M Q2 '22 — Net Income: -53.5M Q3 '22 — Revenue: 42K Q3 '22 — Operating Cash Flow: -48M Q3 '22 — Free Cash Flow: -48.6M Q3 '22 — Net Income: -55.7M Q4 '22 — Revenue: 6.5M Q4 '22 — Operating Cash Flow: -42.3M Q4 '22 — Free Cash Flow: -42.9M Q4 '22 — Net Income: -60.7M Q1 '23 — Revenue: 9.9M Q1 '23 — Operating Cash Flow: -35.8M Q1 '23 — Free Cash Flow: -37.6M Q1 '23 — Net Income: -49M Q2 '23 — Revenue: 2.9M Q2 '23 — Operating Cash Flow: -38.7M Q2 '23 — Free Cash Flow: -40M Q2 '23 — Net Income: -40.3M Q3 '23 — Revenue: 5.3M Q3 '23 — Operating Cash Flow: -35.5M Q3 '23 — Free Cash Flow: -35.7M Q3 '23 — Net Income: -45M Q4 '23 — Revenue: 60M Q4 '23 — Operating Cash Flow: -22.2M Q4 '23 — Free Cash Flow: -23.5M Q4 '23 — Net Income: -18.9M Q1 '24 — Revenue: 1.1M Q1 '24 — Operating Cash Flow: -49.9M Q1 '24 — Free Cash Flow: -51.7M Q1 '24 — Net Income: -62M Q2 '24 — Revenue: 513K Q2 '24 — Operating Cash Flow: -57.1M Q2 '24 — Free Cash Flow: -60.6M Q2 '24 — Net Income: -67.6M Q3 '24 — Revenue: 61K Q3 '24 — Operating Cash Flow: -52.6M Q3 '24 — Free Cash Flow: -55.5M Q3 '24 — Net Income: -62.1M Q4 '24 — Revenue: 30.6M Q4 '24 — Operating Cash Flow: -50.8M Q4 '24 — Free Cash Flow: -51.3M Q4 '24 — Net Income: -45.4M Q1 '25 — Revenue: 4.7M Q1 '25 — Operating Cash Flow: -47.8M Q1 '25 — Free Cash Flow: -47.9M Q1 '25 — Net Income: -76.1M Q2 '25 — Revenue: 3.6M Q2 '25 — Operating Cash Flow: -50.2M Q2 '25 — Free Cash Flow: -50.2M Q2 '25 — Net Income: -53.2M Q3 '25 — Revenue: 7.5M Q3 '25 — Operating Cash Flow: -30.8M Q3 '25 — Free Cash Flow: -31.3M Q3 '25 — Net Income: -25.1M Q4 '25 — Revenue: 24.7M Q4 '25 — Operating Cash Flow: -36.4M Q4 '25 — Free Cash Flow: -36.4M Q4 '25 — Net Income: -5.6M Q1 '26 — Revenue: 2.8M Q1 '26 — Operating Cash Flow: -23.1M Q1 '26 — Free Cash Flow: -23.2M Q1 '26 — Net Income: -25M Q2 '26 — Revenue: 11.9M Q2 '26 — Operating Cash Flow: -29.6M Q2 '26 — Free Cash Flow: -29.7M Q2 '26 — Net Income: -18.2M -60M -30M 0 30M 60M 90M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.3
SBC / sales 18.4%
OE margin -274.9%
Oper. margin -161.4%
Accruals 19.3%
EBITDA margin -156.2%
FCF margin -256.5%
OCF margin -255.0%
Profit margin -157.3%
ROA -31.2%
ROCE -44.9%
ROE -70.2%
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 0.69×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -12.3×
Cash / Debt 3.8×
Debt payback 0.0 yr
Quick ratio 3.2×
Debt / Eq 0.53×
Cash runway 1.3 yr
F-score 1.1 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.7
Sales CAGR 4Y +12.2%
Sales/sh Y/Y +12.1%
Sales Q/Q +232.3%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.